Health, Beauty And Wellness News: FTC, FDA Enforcement, Noosh In Vitamin Shoppe, GNC Tests Store Features
This article was originally published in The Rose Sheet
Dr. Schulze's warned on cancer claims; Nutrition 21 ingredients in BPI Sports, Olympus Labs supplements; GNC tests 'experiential' store features, helps promote ZanthSyn; Noosh Almond Protein in Vitamin Shoppe; and FTC says no more, Nobetes.
You may also be interested in...
The Federal Trade Commission has long held that Section 13(b) of the FTC Act authorizes the agency to seek permanent injunctions against, and monetary relief from, alleged violators of consumer protection provisions. But that understanding is being put to the test, and cracks are beginning to show, attorneys say.
FTC on consecutive days announced court order closing a California business allegedly charging consumers for products and enrolling them in negative-option continuity plans without their consent after they responded to bogus free trial online offers, and started mailing 16,596 checks totaling more than $750,000 to consumers who bought deceptively marketed supplements from a Maine firm that also lured customers with a free trial pitch.
Lucky STAR: FDA’s eSTAR Pilot Aims To Make 510(k) Process Smoother With Submission Template For Device Makers
Nine lucky manufacturers will soon have the chance to enroll in a voluntary eSTAR pilot program that the US agency says will make the premarket review process more efficient and consistent. The design and structure of an electronic Submission Template And Resource – or eSTAR – template is similar to templates used by FDA reviewers. An eSTAR won’t change the agency’s statutory or data requirements for sponsors to show substantial equivalence to predicate devices.